{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:11:47Z","timestamp":1791216707023,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020050","name":"Japan Intractable Diseases Research Foundation","doi-asserted-by":"publisher","award":["23FC1048"],"award-info":[{"award-number":["23FC1048"]}],"id":[{"id":"10.13039\/100020050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10157-026-02894-x","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T03:05:35Z","timestamp":1779764735000},"page":"1332-1340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nationwide epidemiological survey of autosomal dominant polycystic kidney disease in Japan in 2022"],"prefix":"10.1007","volume":"30","author":[{"given":"Shinya","family":"Nakatani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryousuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ohfuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakaba","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-5195","authenticated-orcid":false,"given":"Satoru","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"2S","key":"2894_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2024.07.009","volume":"107","author":"Kidney Disease: Improving Global Outcomes AWG","year":"2025","unstructured":"Kidney Disease: Improving Global Outcomes AWG. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int. 2025;107(2S):S1\u2013239. https:\/\/doi.org\/10.1016\/j.kint.2024.07.009.","journal-title":"Kidney Int"},{"issue":"8","key":"2894_CR2","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","volume":"32","author":"CJ Willey","year":"2017","unstructured":"Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transpl. 2017;32(8):1356\u201363. https:\/\/doi.org\/10.1093\/ndt\/gfw240.","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"2894_CR3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.34067\/KID.0004522021","volume":"2","author":"TT Aung","year":"2021","unstructured":"Aung TT, Bhandari SK, Chen Q, Malik FT, Willey CJ, Reynolds K, et al. Autosomal Dominant Polycystic Kidney Disease Prevalence among a Racially Diverse United States Population, 2002 through 2018. Kidney360. 2021;2(12):2010\u20135. https:\/\/doi.org\/10.34067\/KID.0004522021.","journal-title":"Kidney360"},{"issue":"1","key":"2894_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2215\/CJN.05900519","volume":"15","author":"T Suwabe","year":"2020","unstructured":"Suwabe T, Shukoor S, Chamberlain AM, Killian JM, King BF, Edwards M, et al. Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County. Clin J Am Soc Nephrol. 2020;15(1):69\u201379. https:\/\/doi.org\/10.2215\/CJN.05900519.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2894_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000045214","volume":"80","author":"E Higashihara","year":"1998","unstructured":"Higashihara E, Nutahara K, Kojima M, Tamakoshi A, Yoshiyuki O, Sakai H, et al. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron. 1998;80(4):421\u20137. https:\/\/doi.org\/10.1159\/000045214.","journal-title":"Nephron"},{"key":"2894_CR6","unstructured":"Nakamura Y, The Study Group on Epidemiologic Research for Intractable Diseases. A manual of a nationwide epidemiological survey for estimating the number of patients and assessing clinicoepidemiological characteristics of patients with intractable diseases. [in Japanese]. 3rd ed; 2017. https:\/\/plaza.umin.ac.jp\/~nanbyouekigaku\/wp-content\/themes\/template\/assets\/pdf\/manual.pdf Accessed 9 Feb 2025."},{"issue":"10","key":"2894_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/hepr.14040","volume":"54","author":"S Ohfuji","year":"2024","unstructured":"Ohfuji S, Tanaka A, Kogiso T, Kanto T. Epidemiology of Fontan-associated liver disease in Japan: Results from a nationwide survey in 2021. Hepatol Res. 2024;54(10):931\u201341. https:\/\/doi.org\/10.1111\/hepr.14040.","journal-title":"Hepatol Res"},{"issue":"6","key":"2894_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/mr\/roae010","volume":"34","author":"M Kawazoe","year":"2024","unstructured":"Kawazoe M, Nanki T, Saeki K, Ishikawa H, Nakamura Y, Kawashima S, et al. Nationwide epidemiological survey of polyarteritis nodosa in Japan in 2020. Mod Rheumatol. 2024;34(6):1284\u20137. https:\/\/doi.org\/10.1093\/mr\/roae010.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"2894_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/mr\/road019","volume":"34","author":"N Konda","year":"2023","unstructured":"Konda N, Sakai R, Saeki K, Matsubara Y, Nakamura Y, Miyamae T, et al. Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017. Mod Rheumatol. 2023;34(1):167\u201374. https:\/\/doi.org\/10.1093\/mr\/road019.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"2894_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/kisup.2015.5","volume":"5","author":"N Hanafusa","year":"2015","unstructured":"Hanafusa N, Nakai S, Iseki K, Tsubakihara Y. Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis population. Kidney Int Suppl (2011). 2015;5(1):15\u201322. https:\/\/doi.org\/10.1038\/kisup.2015.5.","journal-title":"Kidney Int Suppl (2011)"},{"key":"2894_CR11","unstructured":"JSDT. WADDA system Ver2.1. April 15. 2025, https:\/\/member.jsdt.or.jp\/member\/statistics, (Retrieved February 9, 2026)."},{"key":"2894_CR12","first-page":"197","volume":"58","author":"The Japan Society for Transplantation and Japanese Society for Clinical Renal Transplantation","year":"2023","unstructured":"The Japan Society for Transplantation and Japanese Society for Clinical Renal Transplantation. Table 9, Underlying disease of the recipient, Annual progress report from the Japanese renal transplant registry: number of renal transplantations in 2022 and follow-up survey. Jap J Transpl. 2023;58:197. (in Japanese).","journal-title":"Jap J Transpl"},{"issue":"12","key":"2894_CR13","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s10157-021-02097-6","volume":"25","author":"S Nishio","year":"2021","unstructured":"Nishio S, Tsuchiya K, Nakatani S, Muto S, Mochizuki T, Kawano H, et al. A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020. Clin Exp Nephrol. 2021;25(12):1292\u2013302. https:\/\/doi.org\/10.1007\/s10157-021-02097-6.","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"2894_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/hepr.13343","volume":"49","author":"S Ohfuji","year":"2019","unstructured":"Ohfuji S, Furuichi Y, Akahoshi T, Kage M, Obara K, Hashizume M, et al. Japanese periodical nationwide epidemiologic survey of aberrant portal hemodynamics. Hepatol Res. 2019;49(8):890\u2013901. https:\/\/doi.org\/10.1111\/hepr.13343.","journal-title":"Hepatol Res"},{"issue":"2","key":"2894_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.11152\/mu-3330","volume":"24","author":"M Kobayashi","year":"2022","unstructured":"Kobayashi M, Kamai T. Epidemiological estimates and early detection of polycystic kidney disease by ultrasonographic assessment in Japan. Med Ultrason. 2022;24(2):140\u20135. https:\/\/doi.org\/10.11152\/mu-3330.","journal-title":"Med Ultrason"},{"issue":"9","key":"2894_CR16","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10157-021-02083-y","volume":"25","author":"S Muto","year":"2021","unstructured":"Muto S, Okada T, Shibasaki Y, Ibuki T, Horie S. Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan. Clin Exp Nephrol. 2021;25(9):1003\u201310. https:\/\/doi.org\/10.1007\/s10157-021-02083-y.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"2894_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10157-015-1086-2","volume":"19","author":"S Muto","year":"2015","unstructured":"Muto S, Kawano H, Higashihara E, Narita I, Ubara Y, Matsuzaki T, et al. The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. Clin Exp Nephrol. 2015;19(5):867\u201377. https:\/\/doi.org\/10.1007\/s10157-015-1086-2.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"2894_CR18","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","volume":"28","author":"HP Neumann","year":"2013","unstructured":"Neumann HP, Jilg C, Bacher J, Nabulsi Z, Malinoc A, Hummel B, et al. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transpl. 2013;28(6):1472\u201387. https:\/\/doi.org\/10.1093\/ndt\/gfs551.","journal-title":"Nephrol Dial Transpl"},{"key":"2894_CR19","doi-asserted-by":"publisher","unstructured":"Sekine A, Hidaka S, Moriyama T, Shikida Y, Shimazu K, Ishikawa E, et al. Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD). J Clin Med. 2022;11(21). https:\/\/doi.org\/10.3390\/jcm11216528.","DOI":"10.3390\/jcm11216528"},{"issue":"8","key":"2894_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.34067\/KID.0002262020","volume":"1","author":"R Inoue","year":"2020","unstructured":"Inoue R, Nishi H, Inoue D, Honda K, Nangaku M. Regional Variance of the Early Use of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease. Kidney360. 2020;1(8):740\u20135. https:\/\/doi.org\/10.34067\/KID.0002262020.","journal-title":"Kidney360"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02894-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:46:37Z","timestamp":1787723197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02894-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02894-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors have declared no competing interest relevant to this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed according to ethical guidelines for medical and health research involving human subjects provided by the Japanese Ministry of Health, Labour and Welfare, as well as the Declaration of Helsinki. The protocol of this investigation was approved by the Ethics Committee of Osaka Metropolitan University (No. 2024-088).","order":2,"name":"Ethics","label":"Research involving human participants","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An opt-out option was provided, as explained in information posted on the institutional website.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}